Nymox Pharmaceutical Corporation NYMX

Quarterly report 2024-Q4
added 06-03-2026

Nymox Pharmaceutical Corporation DIO Ratio 2011-2026 | NYMX

Annual DIO Ratio Nymox Pharmaceutical Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	5.46	85.7	186	29.8	61.1	29.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
186	5.46	66.2

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	FSD Pharma HUGE	174	-	5743.5 %	$ 69.7 M	Canada
	Happiness Biotech Group Limited HAPP	1.91 K	-	1.35 %	$ 17.8 M	China
	Coherus BioSciences CHRS	97.5	$ 1.58	7.14 %	$ 185 M	USA
	Deciphera Pharmaceuticals DCPH	2.04 K	-	-	$ 2.18 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Affimed N.V. AFMD	69.8	-	-34.95 %	$ 21.5 M	Germany
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
	Anika Therapeutics ANIK	159	$ 14.79	2.64 %	$ 212 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 21.95	2.81 %	$ 2.79 B	USA